| Recruiting | A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma Primary Vitreoretinal Lymphoma | Phase 3 | 2026-02-01 |
| Completed | A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1) Alcohol Hepatitis | Phase 2 | 2024-11-04 |
| Completed | A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease Dry Eye Disease | Phase 3 | 2024-06-24 |
| Completed | A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease Dry Eye Disease | Phase 3 | 2024-04-29 |
| Completed | A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease Dry Eye Disease | Phase 3 | 2024-04-09 |
| Completed | A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) Atopic Dermatitis | Phase 2 | 2023-02-15 |
| Withdrawn | Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Nephrotic Syndrome | Phase 2 | 2023-01-01 |
| Completed | A Study in Subjects With Retinitis Pigmentosa Retinitis Pigmentosa | Phase 2 | 2022-07-14 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough Chronic Cough | Phase 2 | 2022-04-07 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease Dry Eye Syndromes | Phase 2 | 2022-03-09 |
| Completed | The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Allergic Conjunctivitis | Phase 3 | 2022-01-21 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels Ethanol Intoxication | Phase 1 / Phase 2 | 2021-11-15 |
| Completed | An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Dis Dry Eye | Phase 2 | 2021-09-09 |
| Completed | The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye D Dry Eye | Phase 3 | 2021-08-28 |
| Completed | A Clinical Trial to Assess Subjects With Dry Eye Disease. Dry Eye | Phase 2 | 2021-06-15 |
| Completed | A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2021-05-07 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, Covid19 | Phase 2 | 2021-03-31 |
| Completed | A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Sa Dry Eye Disease | Phase 3 | 2021-01-26 |
| Completed | A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficac Atopic Asthma | Phase 2 | 2021-01-09 |
| Completed | The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease Dry Eye, Dry Eye Syndromes | Phase 2 / Phase 3 | 2020-11-21 |
| Completed | The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Co Allergic Conjunctivitis | Phase 3 | 2019-12-05 |
| Completed | The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Proliferative Vitreoretinopathy | Phase 3 | 2019-11-15 |
| Completed | A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Dry Eye | Phase 2 | 2019-04-23 |
| Completed | The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase Dry Eye | Phase 3 | 2019-04-16 |
| Completed | A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using Conjunctivitis, Allergic | Phase 1 / Phase 2 | 2018-10-02 |
| Completed | A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjun Allergic Conjunctivitis | Phase 1 / Phase 2 | 2018-09-08 |
| Completed | RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS) Sjogren-Larsson Syndrome | Phase 3 | 2018-07-18 |
| Completed | ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis Allergic Conjunctivitis | Phase 3 | 2018-03-30 |
| Completed | A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Sa Dry Eye Syndrome | Phase 2 | 2018-01-02 |
| Completed | A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome Dry Eye Syndromes | Phase 2 | 2017-05-15 |
| Completed | SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis. Non-infectious Anterior Uveitis | Phase 3 | 2017-04-26 |
| Completed | A Study of ADX-102 in Subjects With Allergic Conjunctivitis Conjunctivitis, Allergic | Phase 2 | 2016-12-01 |
| Completed | A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis Allergic Conjunctivitis, Seasonal Allergies | Phase 2 | 2015-08-01 |
| Completed | A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS) Sjögren-Larsson Syndrome | Phase 2 | 2015-03-01 |
| Completed | A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis Non-infectious Anterior Uveitis | Phase 2 | 2015-03-01 |